Financhill
Back

ZimVie Vs. Perspective Therapeutics Industry Stock Comparison

Sell
33

ZIMV
ZimVie

Last Price:
$14.01
Seasonality Move:
-9.27%
Sell
25

CATX
Perspective Therapeutics

Last Price:
$3.50
Seasonality Move:
43.39%
Sell
33
ZimVie (ZIMV) is a Sell

Is ZimVie a Buy, Sell or Hold?

  • The current ZimVie [ZIMV] share price is $13.99. The Score for ZIMV is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ZIMV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.51. The Score for CATX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ZIMV Stock Price Chart

What is ZimVie's stock price today?

  • The ZimVie share price today is $13.99
    The current trend is relatively stagnant and ZIMV is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZIMV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 49.81 Sell
Chaikin Money Flow: 28313 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.68 - 14.44) Sell
Bollinger Bands (100): (13.81 - 16.51) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 37.48 Sell
Chaikin Money Flow: 704863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.07 - 3.87) Buy
Bollinger Bands (100): (5.54 - 14.76) Sell

ZIMV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.93 Buy
20-day SMA: 13.9 Buy
50-day SMA: 14.02 Sell
200-day SMA: 16.21 Sell
8-day EMA: 13.91 Buy
20-day EMA: 13.95 Buy
50-day EMA: 14.29 Sell
200-day EMA: 15.35 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.24 Buy
20-day SMA: 3.32 Buy
50-day SMA: 6.48 Sell
200-day SMA: 11.89 Sell
8-day EMA: 3.27 Buy
20-day EMA: 3.68 Sell
50-day EMA: 5.95 Sell
200-day EMA: 9.5 Sell

ZimVie Earnings Growth & ZIMV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.05 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.35 per share.

ZimVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):